Health Trials

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

ConditionsJuvenile Idiopathic ArthritisRheumatoid ArthritisPsoriatic ArthritisSystemic Lupus ErythematosusDiffuse Systemic SclerosisSeronegative Arthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-50
SponsorUniversité Catholique de Louvain

About this trial

Population:

Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS).

Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.

These 5 cohorts will be subject to standardized clinical monitoring.

Eligibility criteria

Qualifiers

Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria).

Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.

Disqualifiers

Treated for > 3 months

> 50 years old

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 5 trial groups

Sponsors and collaborators

Université Catholique de Louvain

Lead sponsor

Source ClinicalTrials.gov